Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

IAM Patent 1000 2024 Ranks Cravath in Gold Tier and Recognizes Five Cravath Attorneys

June 13, 2024

The IAM Patent 1000 2024, which recognizes the firms and individuals “deemed outstanding in the pivotal area of patent law,” ranked Cravath in the top tier for New York across Litigation and Transactions. In addition, Cravath partners Keith R. Hummel, David J. Kappos, David R. Marriott, Sasha Rosenthal‑Larrea and Sharonmoyee Goswami were recognized for their “outstanding service” and representation of clients on litigation and transactional matters including Johnson & Johnson in its $16.6 billion acquisition of Abiomed; Abiomed in its victory before the U.S. Patent Trial and Appeal Board; and Truist Bank in patent infringement litigation brought by United Services Automobile Association. 

Related Practices & Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Intellectual Property Litigation
  • Healthcare and Life Sciences
  • Financial Services and Insurance

People

Photo
Name
Keith R. Hummel
Title
Litigation
Title
Partner
Email
khummel@cravath.com
Phone
+1-212-474-1772
vCard
Download vCard

    Education

    • J.D., 1990, Georgetown University Law Center
      Order of the Coif, magna cum laude
    • B.A., 1987, University of Notre Dame

    Admitted In

    • New York
    Photo
    Name
    David J. Kappos
    Title
    Corporate
    Title
    Partner
    Email
    dkappos@cravath.com
    Phone
    +1-212-474-1168
    vCard
    Download vCard

      Education

      • J.D., 1990, University of California, Berkeley, School of Law
      • B.S., 1983, University of California, Davis
        summa cum laude

      Admitted In

      • New York
      • California
      • District of Columbia
      Photo
      Name
      David R. Marriott
      Title
      Litigation
      Title
      Partner
      Email
      dmarriott@cravath.com
      Phone
      +1-212-474-1430
      vCard
      Download vCard

        Education

        • J.D., 1994, New York University School of Law
        • B.A., 1991, Brigham Young University
          magna cum laude

        Admitted In

        • New York
        Photo
        Name
        Sasha Rosenthal-Larrea
        Title
        Corporate
        Title
        Partner
        Email
        srosenthal-larrea@cravath.com
        Phone
        +1-212-474-1967
        vCard
        Download vCard

          Education

          • J.D., 2010, Columbia Law School
            Harlan Fiske Stone Scholar
          • A.B., 2007, Brown University

          Admitted In

          • New York
          Photo
          Name
          Sharonmoyee Goswami
          Title
          Litigation
          Title
          Partner
          Email
          sgoswami@cravath.com
          Phone
          +1-212-474-1928
          vCard
          Download vCard

            Education

            • J.D., 2012, New York University School of Law
              Order of the Coif, magna cum laude
            • B.S.E., 2009, Princeton University

            Admitted In

            • New York

            Related News & Insights

            Deals & Cases

            November 01, 2022

            Johnson & Johnson’s $16.6 Billion Acquisition of Abiomed

            On November 1, 2022, Johnson & Johnson and Abiomed, a leader in breakthrough heart, lung and kidney support technologies, announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. Abiomed shareholders will also receive a non-tradeable contingent value right (“CVR”) entitling the holder to receive up to $35 per share in cash if certain commercial and clinical milestones are achieved. Cravath is representing Johnson & Johnson in connection with the transaction.

            Deals & Cases

            January 31, 2023

            Abiomed Secures Victory Before the U.S. Patent Trial and Appeal Board

            In January, 2023, Cravath client Abiomed Inc. (“Abiomed”) secured a victory before the U.S. Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”).

            Cravath Bicentennial

            Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

            Explore

            Cravath, Swaine & Moore LLP Logo
            • CONTACT US
            • OUR STORY
            • ALUMNI PORTAL
            • DISCLAIMERS & NOTICES

            Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.